annual CFF:
$277.00M+$244.00M(+739.39%)Summary
- As of today (September 16, 2025), RCUS annual cash flow from financing activities is $277.00 million, with the most recent change of +$244.00 million (+739.39%) on December 31, 2024.
- During the last 3 years, RCUS annual CFF has risen by +$40.00 million (+16.88%).
- RCUS annual CFF is now -36.90% below its all-time high of $439.00 million, reached on December 31, 2020.
Performance
RCUS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$52.00M-$90.00M(-63.38%)Summary
- As of today (September 16, 2025), RCUS quarterly cash flow from financing activities is $52.00 million, with the most recent change of -$90.00 million (-63.38%) on June 30, 2025.
- Over the past year, RCUS quarterly CFF has increased by +$50.00 million (+2500.00%).
- RCUS quarterly CFF is now -84.19% below its all-time high of $328.87 million, reached on June 30, 2020.
Performance
RCUS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$240.00M+$50.00M(+26.32%)Summary
- As of today (September 16, 2025), RCUS TTM cash flow from financing activities is $240.00 million, with the most recent change of +$50.00 million (+26.32%) on June 30, 2025.
- Over the past year, RCUS TTM CFF has stayed the same.
- RCUS TTM CFF is now -63.66% below its all-time high of $660.51 million, reached on March 31, 2021.
Performance
RCUS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RCUS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +739.4% | +2500.0% | 0.0% |
| 3 y3 years | +16.9% | +1200.0% | +658.3% |
| 5 y5 years | +10000.0% | -84.2% | -27.3% |
RCUS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +739.4% | -77.3% | +2700.0% | -14.9% | +1163.2% |
| 5 y | 5-year | -36.9% | >+9999.0% | -84.2% | +2700.0% | -63.7% | +1163.2% |
| alltime | all time | -36.9% | >+9999.0% | -84.2% | +2700.0% | -63.7% | >+9999.0% |
RCUS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $52.00M(-63.4%) | $240.00M(+26.3%) |
| Mar 2025 | - | $142.00M(-7200.0%) | $190.00M(-31.4%) |
| Dec 2024 | $277.00M(+739.4%) | -$2.00M(-104.2%) | $277.00M(-1.8%) |
| Sep 2024 | - | $48.00M(+2300.0%) | $282.00M(+17.5%) |
| Jun 2024 | - | $2.00M(-99.1%) | $240.00M(-8.0%) |
| Mar 2024 | - | $229.00M(+7533.3%) | $261.00M(+690.9%) |
| Dec 2023 | $33.00M(0.0%) | $3.00M(-50.0%) | $33.00M(-19.5%) |
| Sep 2023 | - | $6.00M(-73.9%) | $41.00M(+7.9%) |
| Jun 2023 | - | $23.00M(+2200.0%) | $38.00M(+100.0%) |
| Mar 2023 | - | $1.00M(-90.9%) | $19.00M(-42.4%) |
| Dec 2022 | $33.00M(-86.1%) | $11.00M(+266.7%) | $33.00M(-1.0%) |
| Sep 2022 | - | $3.00M(-25.0%) | $33.33M(+5.3%) |
| Jun 2022 | - | $4.00M(-73.3%) | $31.65M(+5.9%) |
| Mar 2022 | - | $15.00M(+32.4%) | $29.88M(-87.4%) |
| Dec 2021 | $237.00M | $11.33M(+759.7%) | $237.00M(+4.1%) |
| Sep 2021 | - | $1.32M(-40.9%) | $227.67M(-31.8%) |
| Jun 2021 | - | $2.23M(-99.0%) | $333.87M(-49.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $222.12M(>+9900.0%) | $660.51M(+50.5%) |
| Dec 2020 | $439.00M(>+9900.0%) | $2.00M(-98.1%) | $439.00M(+0.3%) |
| Sep 2020 | - | $107.52M(-67.3%) | $437.52M(+32.6%) |
| Jun 2020 | - | $328.87M(>+9900.0%) | $329.96M(>+9900.0%) |
| Mar 2020 | - | $610.00K(+17.3%) | $1.74M(+54.8%) |
| Dec 2019 | $1.12M(-99.1%) | $520.00K(-1368.3%) | $1.12M(-18.3%) |
| Sep 2019 | - | -$41.00K(-106.3%) | $1.37M(-2.4%) |
| Jun 2019 | - | $649.00K(<-9900.0%) | $1.41M(-492.2%) |
| Mar 2019 | - | -$5000.00(-100.6%) | -$359.00K(-100.3%) |
| Dec 2018 | $129.07M(+20.2%) | $771.00K(<-9900.0%) | $129.07M(-45.1%) |
| Sep 2018 | - | -$7000.00(-99.4%) | $234.90M(-0.1%) |
| Jun 2018 | - | -$1.12M(-100.9%) | $235.10M(-0.7%) |
| Mar 2018 | - | $129.43M(+21.4%) | $236.79M(+120.5%) |
| Dec 2017 | $107.40M(+53.2%) | $106.60M(>+9900.0%) | $107.40M(>+9900.0%) |
| Sep 2017 | - | $189.00K(-67.4%) | $797.00K(+31.1%) |
| Jun 2017 | - | $579.00K(+1896.6%) | $608.00K(+1996.6%) |
| Mar 2017 | - | $29.00K | $29.00K |
| Dec 2016 | $70.10M | - | - |
FAQ
- What is Arcus Biosciences, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. annual CFF year-on-year change?
- What is Arcus Biosciences, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. quarterly CFF year-on-year change?
- What is Arcus Biosciences, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. TTM CFF year-on-year change?
What is Arcus Biosciences, Inc. annual cash flow from financing activities?
The current annual CFF of RCUS is $277.00M
What is the all time high annual CFF for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high annual cash flow from financing activities is $439.00M
What is Arcus Biosciences, Inc. annual CFF year-on-year change?
Over the past year, RCUS annual cash flow from financing activities has changed by +$244.00M (+739.39%)
What is Arcus Biosciences, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of RCUS is $52.00M
What is the all time high quarterly CFF for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high quarterly cash flow from financing activities is $328.87M
What is Arcus Biosciences, Inc. quarterly CFF year-on-year change?
Over the past year, RCUS quarterly cash flow from financing activities has changed by +$50.00M (+2500.00%)
What is Arcus Biosciences, Inc. TTM cash flow from financing activities?
The current TTM CFF of RCUS is $240.00M
What is the all time high TTM CFF for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high TTM cash flow from financing activities is $660.51M
What is Arcus Biosciences, Inc. TTM CFF year-on-year change?
Over the past year, RCUS TTM cash flow from financing activities has changed by $0.00 (0.00%)